The performance of companies tied to flagship drugs like Viagra presents a nuanced investment landscape . While the initial surge of copyright, fueled by Viagra's unprecedented popularity, generated substantial wealth , the patent expiration in key markets has introduced significant volatility. Investors are now grappling with the impact of lower-c